Abstract
A retrospective study was undertaken to evaluate visual outcome of 11 patients (13 eyes) with central Eales disease (median age, 22 years). All patients had raised erythrocyte sedimentation rates. Nonischemic disease developed in 11 eyes, and 2 eyes had ischemic disease. All patients were administered systemic corticosteroid therapy. One patient with ischemic disease also received panretinal photocoagulation. Final visual acuity of 6/6 was achieved in 7 eyes in the nonischemic group.
Similar content being viewed by others
References
Gieser SC, Murphy RP. Eales' disease. In: Ryan SJ, ed. Medical Retina, St. Louis, Mo: CV Mosby; 1994:1503–1507. Ryan SJ, ed. Retina; vol. 2.
Kumar D, Saxena RC, Saxena S. Vitreous haemorrhage in Eales disease. Afro-Asian J Opthalmol. 1995;13:109–112.
Gieser SC, Murphy RP, Das TP. Eales disease. In: Roy FH, ed. Master Techniques in Ophthalmology, Philadelphia, Pa: Williams & Wilkins; 1995:1063–1068.
Saxena S, Kumar D, Singh VK, Rajasingh J. Immunological studies in Eales' disease: a review. Afro-Asian J Ophthalmol.. 1995;13:19–22.
Muthukkaruppan VR, Rengarajan K, Chakkalath HR, Namperumalsamy P. Immunological status of patients of Eales' disease. Ind J Med Res. 1989;90:351–359.
Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Opthalmol. 1993;37:393–417.
Duke-Elder S, Dobree JH. Vasculitis. In: Duke-Elder S, ed. System of Opthalmology, vol. 10 London, England: Henry Kimpton; 1967:218–236.
Palmer HE, Stanford MR, Sanders MD, Graham EM. Visual outcome of patients with idiopathic ischaemic and nonischemic retinal vasculitis. Eye. 1996;10:343–348.
Stanford MR, Graham EM, Kasp E, et al. A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol. 1988;72:442–447.
Howe LJ, Stanford MR, Edelsten C, Graham EM. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye. 1994;8:443–447.
Walters RF, Spalton DJ. Gentral retinal vein occulusion in people aged 40 years or less: a review of 17 patients. Br J Ophthalmol. 1990;74:30–35.
Ellis CJ, Hamer DB, Hunt RW, et al. Medical investigation of retinal vascular occulusion. Br Med J. 1964;2:1093–1098.
Brown GC, Shah HG, Magargal LE, et al. CRVO and carotid artery disease. Ophthalmology. 1984;91:1627–1633.
Dodson PM, Galton DJ, Hamilton AM, et al. Retinal vein occlusion and prevalence of lipoprotein abnormalities. Br J Ophthalmol. 1992; 66:161–164.
Quinlan PM, Elamn MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol. 1990;110:118–123.
Kohner FM, Cappin JM. Do medical conditions have an influence on CRVO?. Proc R Soc Med. 1974;67:1052–1054.
Priluck IA, Robertson DM, Hollenhurst RW. Long-term follow-up of occlusion of the central retinal vein in young adults. Am J Ophthalmol. 1980;90:190–202.
McGrath MA, Wechsler F, Hunyor ABL, et al. Systemic factors contributory for retinal vein occlution. Arch Intern Med. 1978;138:216–220.
Frucht J, Yanko L, Merin S. Central retinal vein occlusion in young adults. Acta Ophthalmol. 1984;62:780–786.
Gupta A, Agarwal A, Bansal RK, et al. Ischaemic central retinal vein occlusion in the young. Eye. 1993;7:138–142.
Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales' disease. Ocular Immunol Inflamm. 1993;1:41–48.
Appiah A, Trempe CL. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusion. Ophthalmology. 1989;96:364–366.
Saxena S, Kumar D. Visual outcome of branch retinal vein occlusion in Eales' disease. Ann Ophthalmol. 1999;31:173–175.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saxena, S., Kumar, D. Visual outcome of patients with central eales disease. Ann Ophthalmol 33, 300–302 (2001). https://doi.org/10.1007/s12009-001-0044-7
Issue Date:
DOI: https://doi.org/10.1007/s12009-001-0044-7